Frontiers in Cellular and Infection Microbiology

Article	Citations
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development	584
Antibiotics as Major Disruptors of Gut Microbiota	438
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields	260
Role and Mechanism of Gut Microbiota in Human Disease	252
Antibiotic Resistance: One Health One World Outlook	251
Fungi vs. Fungi in Biocontrol: An Overview of Fungal Antagonists Applied Against Fungal Plant Pathogens	225
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species	200
Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey	184
The Gut Microbiota in Inflammatory Bowel Disease	157
SARS-COV-2 Variants: Differences and Potential of Immune Evasion	156
The Female Vaginal Microbiome in Health and Bacterial Vaginosis	155
Periodontal Disease: The Good, The Bad, and The Unknown	148
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria	133
Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome	128
Wuhan to World: The COVID-19 Pandemic	125
Urinary Microbiome: Yin and Yang of the Urinary Tract	123
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression	113
Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy	112
The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies	109
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics	106
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection	106
Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance	105
Desulfovibrio Bacteria Are Associated With Parkinson’s Disease	104
Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia	104
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus	104

The Role of Porphyromonas gingivalis Outer Membrane Vesicles in Periodontal Disease and Related Systemic Diseases	100
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation	99
Gut Microbiota and Diarrhea: An Updated Review	98
Chitosan-Based Nanoparticles Against Viral Infections	97
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro	97
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial	95
An Update on Molecular Diagnostics for COVID-19	93
Recent Advances in Molecular Diagnostics of Fungal Plant Pathogens: A Mini Review	93
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy	91
Escherichia coli as a Multifaceted Pathogenic and Versatile Bacterium	90
Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review	90
Viral Infections, the Microbiome, and Probiotics	88
Gut Microbiota Status in COVID-19: An Unrecognized Player?	86
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome	81
Understanding bacterial biofilms: From definition to treatment strategies	80
The Impact of Gut Microbiota on Radiation-Induced Enteritis	78
Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens From Bronchoalveolar Lavage Samples	78
Recent advances in recombinase polymerase amplification: Principle, advantages, disadvantages and applications	78
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing	76
Galleria mellonella as a Suitable Model of Bacterial Infection: Past, Present and Future	76
Herpes Simplex Virus Cell Entry Mechanisms: An Update	75
Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation	74
Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis	74
Bacterial Vaginosis: What Do We Currently Know?	73
Mycobacterium abscessus complex: A Review of Recent Developments in an Emerging Pathogen	71
Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease	71
Antibiotic Resistance and Virulence Profiles of Klebsiella pneumoniae Strains Isolated From Different Clinical Sources	70
The Microbiota of the Human Mammary Ecosystem	70
Oxidative Stress and Pathogenesis in Malaria	70
Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota	69
The Gut Microbiota of Critically Ill Patients With COVID-19	68
Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota	68
Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area	68
Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study	68
Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota	67
Antimicrobial Activity of Lemongrass Essential Oil (Cymbopogon flexuosus) and Its Active Component Citral Against Dual-Species Biofilms of Staphylococcus aureus and Candida Species	67
Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants	66
Cutaneous Malassezia: Commensal, Pathogen, or Protector?	66
Breath Biopsy and Discovery of Exclusive Volatile Organic Compounds for Diagnosis of Infectious Diseases	65
Pulsatilla chinensis Saponins Ameliorate Inflammation and DSS-Induced Ulcerative Colitis in Rats by Regulating the Composition and Diversity of Intestinal Flora	65
COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions	65
CRISPR-Based COVID-19 Testing: Toward Next-Generation Point-of-Care Diagnostics	64
The Diagnostic Value of Metagenomic Next–Generation Sequencing in Lower Respiratory Tract Infection	62
Elevated Plasma Fibrinogen Is Associated With Excessive Inflammation and Disease Severity in COVID-19 Patients	62
Bipolaris sorokiniana-Induced Black Point, Common Root Rot, and Spot Blotch Diseases of Wheat: A Review	62
IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection	62
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum?	62
Neuroinflammation, Sleep, and Circadian Rhythms	62
Planctomycetes as Host-Associated Bacteria: A Perspective That Holds Promise for Their Future Isolations, by Mimicking Their Native Environmental Niches in Clinical Microbiology Laboratories	61
Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach	60

RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact	60
Persistent Bacterial Coinfection of a COVID-19 Patient Caused by a Genetically Adapted Pseudomonas aeruginosa Chronic Colonizer	59
The Gut Microbiome and Metabolites Are Altered and Interrelated in Patients With Rheumatoid Arthritis	59
Sugar-Coated Killer: Serotype 3 Pneumococcal Disease	58
Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications	58
The Human Skin Microbiome in Selected Cutaneous Diseases	58
Azole Use in Agriculture, Horticulture, and Wood Preservation – Is It Indispensable?	58
Improving Pulmonary Infection Diagnosis with Metagenomic Next Generation Sequencing	58
Combination Therapies for Biofilm Inhibition and Eradication: A Comparative Review of Laboratory and Preclinical Studies	58
Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation	57
Specific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients	57
Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies	56
Alterations in Urobiome in Patients With Bladder Cancer and Implications for Clinical Outcome: A Single-Institution Study	55
A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19	55
Intracellular Porphyromonas gingivalis Promotes the Proliferation of Colorectal Cancer Cells via the MAPK/ERK Signaling Pathway	55
A Saliva-Based RNA Extraction-Free Workflow Integrated With Cas13a for SARS-CoV-2 Detection	54
Role of Cytokines in Experimental and Human Visceral Leishmaniasis	54
Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems	54
Review: The Emerging Role of Neutrophil Extracellular Traps in Sepsis and Sepsis-Associated Thrombosis	53
The Oral Microbiome in Periodontal Health	53
Extracellular Vesicles in Viral Infections: Two Sides of the Same Coin?	53
Association Between Oral Microbiota and Cigarette Smoking in the Chinese Population	52
The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life	52
Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae	52
Impact of Age and Sex on COVID-19 Severity Assessed From Radiologic and Clinical Findings	52
One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar	51
The Role of Intestinal Dysbacteriosis Induced Arachidonic Acid Metabolism Disorder in Inflammaging in Atherosclerosis	51
The Human Gut Phageome: Origins and Roles in the Human Gut Microbiome	50
Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives	50
Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular Bacterial Infections	50
The Dynamic Roles of the Inner Membrane Complex in the Multiple Stages of the Malaria Parasite	50
Amylases: Biofilm Inducer or Biofilm Inhibitor?	50
Altered Fecal Microbiota Composition in Older Adults With Frailty	50
Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)	50
Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic	49
Acaricides Resistance in Ticks: Selection, Diagnosis, Mechanisms, and Mitigation	49
Extracellular Vesicles in Trypanosomatids: Host Cell Communication	49
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy	49
The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy	48
Alterations of Gastric Microbiota in Gastric Cancer and Precancerous Stages	48
Salmonella Biofilm Formation, Chronic Infection, and Immunity Within the Intestine and Hepatobiliary Tract	48
Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury	48
Tick Saliva and the Alpha-Gal Syndrome: Finding a Needle in a Haystack	48
Gut Microbiota Composition in Prediabetes and Newly Diagnosed Type 2 Diabetes: A Systematic Review of Observational Studies	48
The Role of Tricarboxylic Acid Cycle Metabolites in Viral Infections	47
Salivary Microbiota for Gastric Cancer Prediction: An Exploratory Study	47
Intestinal Microbiota Mediates High-Fructose and High-Fat Diets to Induce Chronic Intestinal Inflammation	47
Vaginal Microbiome Composition in Early Pregnancy and Risk of Spontaneous Preterm and Early Term Birth Among African American Women	47
Gut Microbiota Exceeds Cervical Microbiota for Early Diagnosis of Endometriosis	46
Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management	46
CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics	46
Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome	46
Laboratory Diagnostic Tools for Syphilis: Current Status and Future Prospects	46
Antimicrobial Peptides Human Beta-Defensin-2 and -3 Protect the Gut During Candida albicans Infections Enhancing the Intestinal Barrier Integrity: In Vitro Study	46
Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach	46
Fecal and Serum Metabolomic Signatures and Microbial Community Profiling of Postmenopausal Osteoporosis Mice Model	46
Dysbiosis of Gut Microbiota Is Associated With the Progression of Radiation-Induced Intestinal Injury and Is Alleviated by Oral Compound Probiotics in Mouse Model	46
Gut Microbiome Alterations in Patients With Visceral Obesity Based on Quantitative Computed Tomography	45
Phages in the Gut Ecosystem	45
Synergism of Streptococcus mutans and Candida albicans Reinforces Biofilm Maturation and Acidogenicity in Saliva: An In Vitro Study	45
The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies	45
Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants	44
ACE2 Shedding and the Role in COVID-19	44
Effects of Berberine on the Gastrointestinal Microbiota	44
The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy	44
The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment	44
Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review	44
Recent Advances in Research on Antibacterial Metals and Alloys as Implant Materials	43
Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis	43
Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions	43
Role of Cell Surface Hydrophobicity in the Pathogenesis of Medically-Significant Fungi	43
Alteration of Gut Microbiome and Correlated Lipid Metabolism in Post-Stroke Depression	43
The role of probiotics in vaginal health	42
Clonal Candidemia Outbreak by Candida parapsilosis Carrying Y132F in Turkey: Evolution of a Persisting Challenge	42
Composition and diverse differences of intestinal microbiota in ulcerative colitis patients	42
Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets	42
Unraveling Pseudomonas aeruginosa and Candida albicans Communication in Coinfection Scenarios: Insights Through Network Analysis	42
Short-Chain Fatty Acid and FFAR2 Activation – A New Option for Treating Infections?	42
Foundation and Clinical Evaluation of a New Method for Detecting SARS-CoV-2 Antigen by Fluorescent Microsphere Immunochromatography	42
Exosomes Derived From Alveolar Epithelial Cells Promote Alveolar Macrophage Activation Mediated by miR-92a-3p in Sepsis-Induced Acute Lung Injury	41

Factors Associated With MALDI-TOF Mass Spectral Quality of Species Identification in Clinical Routine Diagnostics	41
Outer membrane vesicles of Porphyromonas gingivalis trigger NLRP3 inflammasome and induce neuroinflammation, tau phosphorylation, and memory dysfunction in mice	41
Bacteriophage Cocktails Protect Dairy Cows Against Mastitis Caused By Drug Resistant Escherichia coli Infection	41
Survival and Control of Campylobacter in Poultry Production Environment	41
High-Throughput Absolute Quantification Sequencing Revealed Osteoporosis-Related Gut Microbiota Alterations in Han Chinese Elderly	41
Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells	41
Prevalence of Fungal and Bacterial Co-Infection in Pulmonary Fungal Infections: A Metagenomic Next Generation Sequencing-Based Study	41
Structure and Function of Oral Microbial Community in Periodontitis Based on Integrated Data	41
Bacteriophage Therapy for Staphylococcus Aureus Infections: A Review of Animal Models, Treatments, and Clinical Trials	41
Low-Abundant Microorganisms: The Human Microbiome’s Dark Matter, a Scoping Review	41
Serological cross-reactivity among common flaviviruses	41
A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes	41
The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease	40
Roles of Gut Microbiota in the Regulation of Hippocampal Plasticity, Inflammation, and Hippocampus-Dependent Behaviors	40
Bacterial and Host Determinants of Group B Streptococcal Vaginal Colonization and Ascending Infection in Pregnancy	40
A comprehensive review of the application of probiotics and postbiotics in oral health	40
Vaginal Microbiota and Cytokine Levels Predict Preterm Delivery in Asian Women	40
Revisiting Campylobacter jejuni Virulence and Fitness Factors: Role in Sensing, Adapting, and Competing	40
Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout	40
The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection	40
Bacillus amyloliquefaciens YN201732 Produces Lipopeptides With Promising Biocontrol Activity Against Fungal Pathogen Erysiphe cichoracearum	40
Toxoplasma gondii Genotyping: A Closer Look Into Europe	40
Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis	40
Global epidemiology, genetic environment, risk factors and therapeutic prospects of mcr genes: A current and emerging update	40
Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease	39
Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson’s disease	39
Washed Microbiota Transplantation Lowers Blood Pressure in Patients With Hypertension	39
Immunometabolism of Macrophages in Bacterial Infections	39
Reverse Transcription Recombinase-Aided Amplification Assay With Lateral Flow Dipstick Assay for Rapid Detection of 2019 Novel Coronavirus	39
The Fungal Microbiome and Asthma	39
Forensic Analysis of Human Microbiome in Skin and Body Fluids Based on Geographic Location	39
Cathepsins in Bacteria-Macrophage Interaction: Defenders or Victims of Circumstance?	39
Next-Generation Sequencing Reveals the Progression of COVID-19	39
Analytical and Clinical Evaluation of “AccuPower SARS-CoV-2 Multiplex RT-PCR kit (Bioneer, South Korea)” and “Allplex 2019-nCoV Assay (Seegene, South Korea)” for SARS-CoV-2 RT-PCR Diagnosis: Korean CD	38
Revisiting the Mechanisms of Immune Evasion Employed by Human Parasites	38
Comparison of Blood Bacterial Communities in Periodontal Health and Periodontal Disease	38
Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer	38
Molecular Mechanisms of Staphylococcus and Pseudomonas Interactions in Cystic Fibrosis	38
Aerobactin Seems To Be a Promising Marker Compared With Unstable RmpA2 for the Identification of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae: In Silico and In Vitro Evidence	37
The Macrophage Response to Mycobacterium tuberculosis and Opportunities for Autophagy Inducing Nanomedicines for Tuberculosis Therapy	37
The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients—A Pilot Study	37
The Development of Ovine Gastric and Intestinal Organoids for Studying Ruminant Host-Pathogen Interactions	37
Akkermansia muciniphila Protects Against Psychological Disorder-Induced Gut Microbiota-Mediated Colonic Mucosal Barrier Damage and Aggravation of Colitis	37
Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn’s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets	37
Role of the PE/PPE Family in Host–Pathogen Interactions and Prospects for Anti-Tuberculosis Vaccine and Diagnostic Tool Design	37
Interfering with Autophagy: The Opposing Strategies Deployed by Legionella pneumophila and Coxiella burnetii Effector Proteins	36
Taxonomic Characterization and Short-Chain Fatty Acids Production of the Obese Microbiota	36
Metagenomic Next-Generation Sequencing for Pathogenic Diagnosis and Antibiotic Management of Severe Community-Acquired Pneumonia in Immunocompromised Adults	36
A Strong Decline in the Incidence of Childhood Otitis Media During the COVID-19 Pandemic in the Netherlands	36
The Complex Interactions Between Rotavirus and the Gut Microbiota	36
COVID-19 Vaccination in Pregnancy and Lactation: Current Research and Gaps in Understanding	36
A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma	36
Distribution, Prevalence, and Causative Agents of Fungal Keratitis: A Systematic Review and Meta-Analysis (1990 to 2020)	36
The Interplay of Host Lysosomes and Intracellular Pathogens	36
Wildlife and Antibiotic Resistance	36
Prevalence, Serotype Distribution and Antimicrobial Resistance of Non-Typhoidal Salmonella in Hospitalized Patients in Conghua District of Guangzhou, China	36
Infections and Pregnancy: Effects on Maternal and Child Health	36
Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease	36
Cross-Kingdom Extracellular Vesicles EV-RNA Communication as a Mechanism for Host–Pathogen Interaction	35
The Role of Neutrophils and Neutrophil Elastase in Pneumococcal Pneumonia	35
Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy	35
Fecal Microbiota Transplantation Protects the Intestinal Mucosal Barrier by Reconstructing the Gut Microbiota in a Murine Model of Sepsis	35
Rapid Detection of Enterocytozoon hepatopenaei Infection in Shrimp With a Real-Time Isothermal Recombinase Polymerase Amplification Assay	35
SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?	35
Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy	35
KAP1/TRIM28: Transcriptional Activator and/or Repressor of Viral and Cellular Programs?	35
SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines	35
Phage Endolysin LysP108 Showed Promising Antibacterial Potential Against Methicillin-resistant Staphylococcus aureus	35
Analysis of Salivary Mycobiome in a Cohort of Oral Squamous Cell Carcinoma Patients From Sudan Identifies Higher Salivary Carriage of Malassezia as an Independent and Favorable Predictor of Overall Su	35
Revisiting ESKAPE Pathogens: virulence, resistance, and combating strategies focusing on quorum sensing	35
Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review	34
More Than Just a Periodontal Pathogen –the Research Progress on Fusobacterium nucleatum	34
From Genes to Transcripts, a Tightly Regulated Journey in Plasmodium	34
Akkermansia muciniphila Exerts Strain-Specific Effects on DSS-Induced Ulcerative Colitis in Mice	34
Gut Microbiota Mediates the Preventive Effects of Dietary Capsaicin Against Depression-Like Behavior Induced by Lipopolysaccharide in Mice	34
The reservoir of latent HIV	34
Mechanisms by Which Traditional Chinese Medicines Influence the Intestinal Flora and Intestinal Barrier	34
Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection	34
Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata	34
No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection	34
The Role of Probiotics in Alleviating Postweaning Diarrhea in Piglets From the Perspective of Intestinal Barriers	34
Global epidemiology of campylobacteriosis and the impact of COVID-19	34
Comparison of Red-Complex Bacteria Between Saliva and Subgingival Plaque of Periodontitis Patients: A Systematic Review and Meta-Analysis	33
Subinhibitory Concentrations of Biogenic Silver Nanoparticles Affect Motility and Biofilm Formation in Pseudomonas aeruginosa	33
Bacterial extracellular vesicles and their novel therapeutic applications in health and cancer	33
Virulence and Antibiotic Resistance Characteristics of Vibrio Isolates From Rustic Environmental Freshwaters	33
NS1: A Key Protein in the “Game” Between Influenza A Virus and Host in Innate Immunity	33
The Modular Circuitry of Apicomplexan Cell Division Plasticity	33
16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary Syndrome	33
Direct Detection and Identification of the Most Common Bacteria and Fungi Causing Otitis Externa by a Stepwise Multiplex PCR	33
Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials	33
Clinical Predictors of COVID-19 Severity and Mortality: A Perspective	33
Phylogenetic Group Distribution of Uropathogenic Escherichia coli and Related Antimicrobial Resistance Pattern: A Meta-Analysis and Systematic Review	33
The Role of Non-Typeable Haemophilus influenzae Biofilms in Chronic Obstructive Pulmonary Disease	33
COVID-19: Molecular and Cellular Response	32